Fujifilm Launches New US Company to Develop Allogeneic iPS Cell-Derived Cancer Immunotherapies

July 3, 2019
Fujifilm said on July 1 that its US-based subsidiary Fujifilm Cellular Dynamics and a US venture capital have set up a new company, Century Therapeutics, in the US to develop allogeneic iPS cell-derived cancer immunotherapies. Fujifilm Cellular Dynamics manufactures allogeneic...read more